Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linos Lazarides

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Organic Letters|May 25, 2002
Synthetic route to the GE3 cyclodepsipeptideKarl J Hale, Linos Lazarides
Chemical Communications (Cambridge, England)|September 26, 2002
Synthesis of an L-proline modified mimetic of the A83586C antitumour cyclodepsipeptideKarl J Hale, Linos Lazarides
Organic Letters|November 18, 2005
O-Directed free-radical hydrostannations of propargyl ethers, acetals, and alcohols with Ph3SnH and Et3BPaschalis Dimopoulos, Audrey Athlan, Soraya Manaviazar, et al.
Organic Letters|January 30, 2009
Synthesis of A83586C analogs with potent anticancer and beta-catenin/ TCF4/osteopontin inhibitory effects and insights into how A83586C modulates E2Fs and pRbKarl J Hale, Soraya Manaviazar, Linos Lazarides, et al.
Nature|January 7, 2015
A new antibiotic kills pathogens without detectable resistanceLosee L Ling, Tanja Schneider, Aaron J Peoples, et al.
Journal of Medicinal Chemistry|January 12, 2017
Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin AVictoria A Steadman, Simon B Pettit, Karine G Poullennec, et al.
Journal of Medicinal Chemistry|February 11, 2016
Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of AsthmaKeith Biggadike, Mahbub Ahmed, Doug I Ball, et al.
Journal of Medicinal Chemistry|August 4, 2018
Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin MacrocycleRichard L Mackman, Victoria A Steadman, David K Dean, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Organic Letters|May 25, 2002
Synthetic route to the GE3 cyclodepsipeptideKarl J Hale, Linos Lazarides
Chemical Communications (Cambridge, England)|September 26, 2002
Synthesis of an L-proline modified mimetic of the A83586C antitumour cyclodepsipeptideKarl J Hale, Linos Lazarides
Organic Letters|November 18, 2005
O-Directed free-radical hydrostannations of propargyl ethers, acetals, and alcohols with Ph3SnH and Et3BPaschalis Dimopoulos, Audrey Athlan, Soraya Manaviazar, et al.
Organic Letters|January 30, 2009
Synthesis of A83586C analogs with potent anticancer and beta-catenin/ TCF4/osteopontin inhibitory effects and insights into how A83586C modulates E2Fs and pRbKarl J Hale, Soraya Manaviazar, Linos Lazarides, et al.
Nature|January 7, 2015
A new antibiotic kills pathogens without detectable resistanceLosee L Ling, Tanja Schneider, Aaron J Peoples, et al.
Journal of Medicinal Chemistry|January 12, 2017
Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin AVictoria A Steadman, Simon B Pettit, Karine G Poullennec, et al.
Journal of Medicinal Chemistry|February 11, 2016
Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of AsthmaKeith Biggadike, Mahbub Ahmed, Doug I Ball, et al.
Journal of Medicinal Chemistry|August 4, 2018
Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin MacrocycleRichard L Mackman, Victoria A Steadman, David K Dean, et al.
Pageof 1